| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| UNITED THERAPEUTICS Corp | 10%+ Owner | $43,870,765 | 12 Dec 2023 | ||
| BAXTER INTERNATIONAL INC | 10%+ Owner | $3,333,333 | 24 Jun 2021 | ||
| Cheshire MD Holdings, LLC | 10%+ Owner | $3,168,146 | 28 Jun 2021 | ||
| Ronald E. Eibensteiner | Director | $319,630 | 28 Jun 2021 | ||
| John Joseph Barry | Vice President Of R&D | $56,776 | 10 Mar 2023 | ||
| Brian Niebur | Chief Financial Officer | $39,469 | 13 Jan 2022 | ||
| Laji Kattungal | Vice President Of Quality | $16,000 | 13 Jan 2022 | ||
| Wagner Mark T. | Director | $5,334 | 28 Jun 2021 | ||
| Peter Maag | Director | 12 Dec 2023 | |||
| Lisa Heine Wipperman | Director | 12 Dec 2023 | |||
| James Michael Douglas | Chief Financial Officer | 12 Dec 2023 | |||
| William P. Mr. Burke | Director | 12 Dec 2023 | |||
| John L. Erb | Director | 12 Dec 2023 | |||
| Paul Buckman | Director | 12 Dec 2023 | |||
| Jeffrey James Ross | CHIEF EXECUTIVE OFFICER, Director | 12 Dec 2023 |
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||